NIRS-IVUS Imaging (TVC Imaging System)
DeviceDiagnostic Imaging Catheter
NCT Number: NCT02033694
The purpose of this study is to enhance medical knowledge of the causes of future coronary problems. Many studies in patients who have already experienced a coronary problem point to the danger associated with plaques that are rich in cholesterol. This study determines if the near-infrared method of detection of these fatty plaques can predict future events. If dangerous plaques can be identified, there are many treatments already available that could be tested for their ability to prevent coronary events.
Looking for future studies?
Notify MeAll sexes
Observational
San Biovanni Hospital, Rome, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
General Inclusion Criteria:
Angiographic Inclusion Criteria
IVUS/NIRS Imaging Inclusion Criterion
Exclusion criteria
Diagnostic Imaging Catheter
Time frame: 2 years
Association of maximum 4 mm Lipid Core Burden Index (maxLCBI4mm) as a continuous value in 100 unit increments in all imaged arteries and NC-MACE at both (1) Patient Level and (2) Plaque Level
Non-Index Culprit Lesion related Major Adverse Cardiac Events (NC-MACE) is defined as a composite of:
Time frame: 2 years
Association of maxLCBI4mm more than and less than a threshold of 400 in all imaged arteries and NC-MACE at both (1) Patient Level and (2) Plaque Level
Non-Index Culprit Lesion related Major Adverse Cardiac Events (NC-MACE) is defined as a composite of:
Infraredx
Industry
The Lipid-Rich Plaque (LRP) Study
Acronym: LRP
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02377310
Arterial Occlusive Diseases, Arteriosclerosis
Glasgow, Dunbartonshire, United Kingdom
View Trial DetailsNCT06508437
Arterial Occlusive Diseases, Arteriosclerosis
Tours, France
View Trial DetailsNCT04382443
Acute Coronary Syndrome, Arterial Occlusive Diseases
Ciudad de Buenos Aires, Buenos Aires, Argentina
View Trial DetailsNCT04460482
Arterial Occlusive Diseases, Arteriosclerosis
Odense, Denmark
View Trial Details